Idorsia
Olivier Lambert has extensive experience in pharmaceutical development and operations, having held various leadership positions in quality assurance, technical project management, and laboratory management at companies like Idorsia Pharmaceuticals Ltd, Actelion, and Novartis. With a background in chemistry and a PhD from Université de Haute-Alsace Mulhouse-Colmar, Olivier Lambert has a proven track record of managing global pharmaceutical development teams and ensuring adherence to quality standards.
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.